Sep 15, 2023IAM/Patent transactions in Q2 2023 soared by 345% YOYJul 17, 2023AST Launches IP3 2023, a Collaborative Fixed-Price, Fixed-Term Patent Purchase ProgramJun 7, 2023IAM/Patent families sold for $83,000 average in latest AST IP3 saleJun 6, 2023AST Announces IP3 2023, a Collaborative Fixed-Price, Fixed-Term Patent Purchase ProgramMay 22, 2023AST Announces Results for IP3 2022 – Collaborative Patent Purchase ProgramJun 24, 2022AST Announces Results for IP3 2021 – Collaborative Patent Purchase ProgramMay 25, 2022AST Announces IP3 2022, a Collaborative Fixed-Price, Fixed-Term Patent Purchase ProgramJun 22, 2021IP3 2021, a Collaborative Fixed Price, Fixed Term Patent Buying Program by AST is Now OpenJun 8, 2021IAM/Patent dealmaking down in the US during Q1 of 2021May 25, 2021IP3 2021 by AST – Collaborative Fixed Price, Fixed Term Patent Buying ProgramMar 9, 2021AST Announces Results for IP3 2020 – Collaborative Patent Purchase ProgramMar 2, 2021AST Achieves Record Breaking Year in Defensive Licenses and Membership Despite Global PandemicDec 3, 2020IAM/Patent deals market dips again as NPEs tighten their grip on the buysideSep 8, 2020LOT Network and AST bring more patent mitigation risk options to Lot Network MembersJun 8, 2020IP3 2020 by AST – Collaborative Fixed Price, Fixed Term Patent Buying ProgramMay 20, 2020Google, Microsoft, Oracle and Uber all back new AST patent buying initiativeMay 20, 2020IAM/AST 4Q Report: IBM, LG and Nokia among top patent sellers in bumper Q1 for dealsMar 11, 2020AST Announces IP3 2019 ResultsMar 2, 2020IAM/AST 4Q Report: Healthcare and pharma slips in latest patent deals but data still points to bumper 2019 for sectorDec 11, 2019IAM/AST 3Q Report: Healthcare and pharma sector sees most patent deals activity in Q3 in the US See More
